For research use only; not for diagnostic procedures. All products to be used in accordance with applicable laws and regulations including without limitation, consumption & disposal requirements under European REACH regulations (EC 1907/2006).
Catenin beta-1 (β-catenin) is a protein that is coded by the CTNNB1 gene. The Wnt/β-Catenin signaling pathway is crucial to regulating cell proliferation and polarity, cell determination, and tissue homeostasis. In the absence of extracellular WNT ligands, cytosolic β-Catenin is phosphorylated, thereby targeting the protein for ubiquitination, degradation, and inactivation. β-Catenin is implicated in various cancers and neurological diseases, such as salivary gland tumors, oral squamous cell carcinomas, Alzheimer’s disease, and Parkinson’s disease.
The AlphaLISA SureFire Ultra Human Phospho-ß-Catenin (Ser37) assay is a sandwich immunoassay for the quantitative detection of phospho-ß-catenin (Ser37) in cellular lysates, using Alpha Technology.
Assay Target | ß-Catenin |
---|---|
Assay Technology | Alpha |
Automation Compatible | Yes |
Detection Method | Alpha |
Experimental Type | In vitro |
Product Brand Name | AlphaLISA SureFire Ultra |
Shipping Condition | Blue Ice |
Target Species | Human |
Therapeutic Area | Central Nervous System, Oncology |
Unit Size | 500 Assay Points |
The introduction of enzyme-linked immunosorbent assays (ELISAs) in the early 1970’s offered researchers a non-radiometric immunoassay platform without compromising sensitivity. Over the last 50 years scientists have made huge strides in disease research and drug discovery and a demand for greater ...
Product brochure for the Alpha Technology, a versatile, no wash, homogeneous assay technology that's suitable for a broad range of applications.
Find out about our range of integrated solutions for drug discovery screening in this e-brochure.
Our screening solutions for high-throughput screening, phenotypic screening and data analysis help to streamline drug discovery workflows in labs across the globe. Our portfolio includes automat ...